SCHEMBL10279860

SCHEMBL10279860

C[C@@H](N)C(=O)c1ccc2c(c1)OCC2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.45
PRKCI P41743 1/20 0.43
TAS1R3 Q7RTX0 3/20 0.41
TAS1R1 Q7RTX1 3/20 0.41
RAB9A P51151 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
CTNNB1 P35222 1/20 0.39
WNT3A P56704 1/20 0.39
NPC1 O15118 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ATM Q13315 1/20 0.39
PIK3CD O00329 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10780145 0.85 TSHR (0.41) TSHRPRKCITAS1R3TAS1R1RAB9A
SCHEMBL4320180 0.80 TSHR (0.68) TSHRPRKCIRAB9ACTNNB1WNT3A
SCHEMBL30344379 0.80 TSHR (0.68) TSHRPRKCIRAB9ACTNNB1WNT3A
SCHEMBL837226 0.80 TAS1R3 (0.43) TSHRTAS1R3TAS1R1RAB9AALDH1A1
SCHEMBL1182047 0.79 KDM4E (0.60) TSHRPRKCITAS1R3TAS1R1RAB9A
SCHEMBL20364677 0.79 CTNNB1 (0.50) TAS1R3TAS1R1RAB9AALDH1A1HPGD
SCHEMBL4685014 0.77 ALDH1A1 (0.55) TSHRPRKCIRAB9AALDH1A1NPC1
SCHEMBL29463151 0.76 ALDH1A1 (0.59) RAB9AALDH1A1HPGDCTNNB1WNT3A
SCHEMBL19932401 0.76 TSHR (0.47) TSHRPRKCITAS1R3TAS1R1RAB9A
SCHEMBL10781619 0.75 ATM (0.69) TSHRTAS1R3TAS1R1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2102169-B1 INDAZOLYL AMIDE DERIVATIVES FOR THE TREATMENT OF GLUCOCORTICOID RECEPTOR MEDIATED DISORDERS ASTRAZENECA AB (SE) 2012-06-20 EP disclosed
WO-2008076048-A1 INDAZOLYL ESTER AND AMIDE DERIVATIVES FOR THE TREATMENT OF GLUCOCORTICOID RECEPTOR MEDIATED DISORDERS ASTRAZENECA AB (SE) 2008-06-26 WO disclosed